SPONSOR
Shandong Suncadia Medicine Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 3
Shandong Suncadia Medicine Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, Type 2 Diabetes.
The trial portfolio spans Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shandong Suncadia Medicine Co., Ltd.
How many clinical trials has Shandong Suncadia Medicine Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shandong Suncadia Medicine Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, Type 2 Diabetes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shandong Suncadia Medicine Co., Ltd. research focus on?
Shandong Suncadia Medicine Co., Ltd. clinical trials span Advanced Solid Tumors, Type 2 Diabetes. The research pipeline includes Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shandong Suncadia Medicine Co., Ltd. clinical trial?
To participate in a Shandong Suncadia Medicine Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shandong Suncadia Medicine Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shandong Suncadia Medicine Co., Ltd.
NCT06770569 Phase 1
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
Advanced Solid Tumors
NCT06589765 Phase 3
Recruiting
A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin
Type 2 Diabetes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology